ZNF385A and ZNF346 Serve as Prognostic Biomarkers Associated with an Inflamed Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma
International Journal of Molecular Sciences · 05.02.2023 · 24 (4) · 3155
DOI: 10.3390/ijms24043155 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.02.2023. Verfasst von Qihang Peng und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science, Yangtze University, Jingzhou 434025, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Hepatitis B, Liver Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province, Scientific research plan project of Hubei Provincial Department of Education.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) has a high mortality rate worldwide, and there are still many problems in the early diagnosis, molecular targeted therapy, and immunotherapy. It is necessary to explore valuable diagnostic markers and new therapeutic targets in HCC. Zinc finger protein 385A (ZNF385A) and zinc finger protein 346 (ZNF346) represent a unique class of RNA-binding Cys2 His2 (C2H2) zinc finger proteins that are involved in the regulation of cell cycle and apoptosis, but little is known of their roles in HCC. Based on multiple databases and analysis tools, we explored the expression, clinical relation, prognostic value, possible biological function, and pathways of ZNF385A and ZNF346, and their relationship with immune infiltration. Our results revealed that ZNF385A and ZNF346 were highly expressed and were associated with poor prognosis in HCC. Hepatitis B virus (HBV) infection may lead to the overexpression of ZNF385A and ZNF346, which was accompanied by elevated apoptosis and chronic inflammation. Moreover, ZNF385A and ZNF346 were positively correlated with immune-suppressive cells, inflammatory cytokines, immune checkpoint genes, and poor immunotherapy efficacy. Finally, the knockdown of ZNF385A and ZNF346 was observed to negatively affect the proliferation and migration of HepG2 cells in vitro. In conclusion, ZNF385A and ZNF346 are promising candidate biomarkers for the diagnosis, prognosis, and response to immunotherapy in HCC, and this study may help to understand the tumor microenvironment (TME) of liver cancer, and to develop new therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Science, Yangtze University, Jingzhou 434025, China.
- College of Life Science and Healthy, Wuhan University of Science and Technology, Wuhan 430072, China.
- State Key Laboratory of Freshwater Ecology and Biotechnology, Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan 430072, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
- Scientific research plan project of Hubei Provincial Department of Education
- Innovation and Entrepreneurship Training Program for College Students of Yangtze University
Zitieren
APA
Peng, Q., Li, J., Wu, Q., Wang, P., Kang, Z., Deng, Y., Xiao, Y., Zheng, P., Ge, F., & Chen, Y. (2023). ZNF385A and ZNF346 Serve as Prognostic Biomarkers Associated with an Inflamed Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma. International Journal of Molecular Sciences, 24(4), 3155. https://doi.org/10.3390/ijms24043155
Vancouver
Peng Q, Li J, Wu Q, Wang P, Kang Z, Deng Y, et al. ZNF385A and ZNF346 Serve as Prognostic Biomarkers Associated with an Inflamed Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 2023;24(4):3155. doi:10.3390/ijms24043155
BibTeX
@article{Peng2023,
author = {Peng, Qihang and Li, Jin and Wu, Qian and Wang, Pei and Kang, Zhongcui and Deng, Yiting and Xiao, Yu and Zheng, Peng and Ge, Feng and Chen, Ying},
title = {ZNF385A and ZNF346 Serve as Prognostic Biomarkers Associated with an Inflamed Immunosuppressive Tumor Microenvironment in Hepatocellular Carcinoma},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {4},
pages = {3155},
doi = {10.3390/ijms24043155}
}
EUVIMED